Ruxolitinib for the treatment of myelofibrosis: its clinical potential

• मुख्य लेखकों: Ostojic A (लेखक), Vrhovac R (लेखक), Verstovsek S (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Dove Medical Press, 2012-03-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Alen Ostojic1, Radovan Vrhovac1, Srdan Verstovsek21Division of Hematology, Department of Internal Medicine, University Hospital Center Zagreb, Zagreb, Croatia; 2Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USAAbstract: Ruxolitinib is an orally bioavailable, se...